Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276

Watchlist Manager
Jiangsu Hengrui Pharmaceuticals Co Ltd Logo
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Watchlist
Price: 48.27 CNY -4.34% Market Closed
Market Cap: 306.5B CNY
Have any thoughts about
Jiangsu Hengrui Pharmaceuticals Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Jiangsu Hengrui Pharmaceuticals Co Ltd

Wall Street analysts forecast Jiangsu Hengrui Pharmaceuticals Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Jiangsu Hengrui Pharmaceuticals Co Ltd is 60.78 CNY with a low forecast of 45.45 CNY and a high forecast of 129.15 CNY.

Lowest
Price Target
45.45 CNY
6% Downside
Average
Price Target
60.78 CNY
26% Upside
Highest
Price Target
129.15 CNY
168% Upside
Jiangsu Hengrui Pharmaceuticals Co Ltd Competitors:
Price Targets
DERM
Journey Medical Corp
90% Upside
CIPLA
Cipla Ltd
12% Upside
4577
Daito Pharmaceutical Co Ltd
32% Upside
VIRP
Virbac SA
27% Upside
OGI
OrganiGram Holdings Inc
76% Upside
OFSA3
Ouro Fino Saude Animal Participacoes SA
5% Downside
4887
Sawai Group Holdings Co Ltd
23% Upside
003090
Daewoong Co Ltd
22% Upside

Revenue
Forecast

Revenue Estimate
Jiangsu Hengrui Pharmaceuticals Co Ltd

For the last 8 years the compound annual growth rate for Jiangsu Hengrui Pharmaceuticals Co Ltd's revenue is 12%. The projected CAGR for the next 3 years is 14%.

12%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Jiangsu Hengrui Pharmaceuticals Co Ltd

For the last 8 years the compound annual growth rate for Jiangsu Hengrui Pharmaceuticals Co Ltd's operating income is 8%. The projected CAGR for the next 3 years is 23%.

8%
Past Growth
23%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Jiangsu Hengrui Pharmaceuticals Co Ltd

For the last 8 years the compound annual growth rate for Jiangsu Hengrui Pharmaceuticals Co Ltd's net income is 9%. The projected CAGR for the next 3 years is 23%.

9%
Past Growth
23%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Jiangsu Hengrui Pharmaceuticals Co Ltd's stock price target?
Price Target
60.78 CNY

According to Wall Street analysts, the average 1-year price target for Jiangsu Hengrui Pharmaceuticals Co Ltd is 60.78 CNY with a low forecast of 45.45 CNY and a high forecast of 129.15 CNY.

What is Jiangsu Hengrui Pharmaceuticals Co Ltd's Revenue forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Jiangsu Hengrui Pharmaceuticals Co Ltd's revenue is 12%. The projected CAGR for the next 3 years is 14%.

What is Jiangsu Hengrui Pharmaceuticals Co Ltd's Operating Income forecast?
Projected CAGR
23%

For the last 8 years the compound annual growth rate for Jiangsu Hengrui Pharmaceuticals Co Ltd's operating income is 8%. The projected CAGR for the next 3 years is 23%.

What is Jiangsu Hengrui Pharmaceuticals Co Ltd's Net Income forecast?
Projected CAGR
23%

For the last 8 years the compound annual growth rate for Jiangsu Hengrui Pharmaceuticals Co Ltd's net income is 9%. The projected CAGR for the next 3 years is 23%.

Back to Top